[Translation] To evaluate the single-center, open-label, randomization of the test formulation, Apixaban Tablets (strength: 2.5 mg), and the reference formulation (Alecto®) (strength: 2.5 mg) in healthy adult subjects in the fasting and postprandial states , single-dose, two-cycle, two-sequence, crossover bioequivalence studies
研究空腹和餐后状态下单次口服受试制剂阿哌沙班片(规格:2.5 mg,湖南赛隆药业有限公司生产)与参比制剂阿哌沙班片(艾乐妥®,规格:2.5 mg;Bristol-Myers Squibb Manufacturing Company生产)在健康受试者体内的药代动力学特征,评价空腹和餐后状态口服两种制剂的生物等效性。
[Translation] A single oral dose of the test preparation Apixaban Tablets (specification: 2.5 mg, produced by Hunan Sailong Pharmaceutical Co., Ltd.) and the reference preparation Apixaban Tablets (Aleto®, specifications: 2.5 mg; manufactured by Bristol-Myers Squibb Manufacturing Company) pharmacokinetic profile in healthy subjects to evaluate the bioequivalence of the two oral formulations in the fasted and fed states.